Sales decline 9.33% to Rs 98.53 crore
Net profit of Tatva Chintan Pharma Chem declined 17.09% to Rs 17.51 crore in the quarter ended March 2022 as against Rs 21.12 crore during the previous quarter ended March 2021. Sales declined 9.33% to Rs 98.53 crore in the quarter ended March 2022 as against Rs 108.67 crore during the previous quarter ended March 2021.For the full year,net profit rose 83.45% to Rs 95.87 crore in the year ended March 2022 as against Rs 52.26 crore during the previous year ended March 2021. Sales rose 44.38% to Rs 433.65 crore in the year ended March 2022 as against Rs 300.36 crore during the previous year ended March 2021.
ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales98.53108.67 -9 433.65300.36 44 OPM %22.2922.52 -24.9622.12 - PBDT21.1226.01 -19 112.3067.43 67 PBT18.9824.24 -22 104.1260.70 72 NP17.5121.12 -17 95.8752.26 83
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
